BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1219052)

  • 1. [Hormonal function of the ovarian corpus luteum during benign mammary diseases].
    Mauvais-Jarvis P; Tamborini A; Sterkers N; Ohlgiesser G; Mowszowicz I
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):965-70. PubMed ID: 1219052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign breast disease I: hormonal investigation.
    Sitruk-Ware R; Sterkers N; Mauvais-Jarvis P
    Obstet Gynecol; 1979 Apr; 53(4):457-60. PubMed ID: 571588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benign breast diseases: hormonal studies in 125 cases (author's transl)].
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Sitruk-Ware R
    Nouv Presse Med; 1977 Dec; 6(44):4115-8. PubMed ID: 600762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate corpus luteal function in women with benign breast diseases.
    Sitruk-ware LR; Sterkers N; Mowszowicz I; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1977 Apr; 44(4):771-4. PubMed ID: 849987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostaglandins and benign mastopathies (author's transl)].
    Rolland PH; Martin PM; Bourry M; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(3):197-201. PubMed ID: 7264251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inadequate corpus luteum function in benign breast-diseases (author's transl)].
    Mauvais-Jarvis P; Ware R; Sterkers N; Ohlgiesser C; Tamborini A
    Ann Endocrinol (Paris); 1976; 37(5):347-54. PubMed ID: 1020920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, hormonal and celioscopic examination of the corpus luteum in sterility without pelvic lesions].
    Agnani G; Colette C; Adessi GL; Del Piano F; Gautier C; Cingotti M
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(1):31-6. PubMed ID: 6853972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma progesterone levels in normal and pregnant Chinese women and effects of contraceptives on them.
    Gu ZP; Wang WC; Lu RF; Jiang XJ
    Chin Med J (Engl); 1980 Aug; 93(8):523-7. PubMed ID: 6772402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle.
    Haukkamaa M; Luukkainen T; Timonen H
    Ann Clin Res; 1974 Feb; 6(1):40-4. PubMed ID: 4820609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclic concentration of estradiol and progesterone in hysterectomized women (author's transl)].
    Reynoso Ron L; Aznar Ramos R; Bedolla Tovar N; Cortés-Gallegos V
    Reproduccion; 1975; 2(1):45-9. PubMed ID: 1181208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease.
    Olsson H; Landin-Olsson M; Gullberg B
    J Natl Cancer Inst; 1983 Jan; 70(1):17-20. PubMed ID: 6571912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
    Zhou YZ; Jiang YX; Sun Q; Zhang SQ; Zhang Y; Chen FL; Lin SQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):609-13. PubMed ID: 12901108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis.
    Rolland PH; Martin PM; Rolland AM; Bourry M; Serment H
    Obstet Gynecol; 1979 Dec; 54(6):715-8. PubMed ID: 514558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of plasma progesterone, oestradiol-17beta and cortisol in ovulatory response to gonadotropin-releasing hormone in dairy cows with cystic follicles.
    Isobe N; Yamada K; Yoshimura Y
    Reprod Domest Anim; 2007 Aug; 42(4):370-5. PubMed ID: 17635773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human benign breast disease: relationships between prostaglandin E2, steroid hormones, and thermographic effects of the inhibitors of PG biosynthesis.
    Rolland PH; Martin PM; Bourry M; Rolland AM; Serment H
    Adv Prostaglandin Thromboxane Res; 1980; 6():581-4. PubMed ID: 7386292
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of clomid induced superovulation on human follicular and luteal function for extracorporeal fertilization and embryo transfer.
    Kerin JF; Warnes GM; Quinn P; Jeffrey R; Godfrey B; Broom TJ; McEvoy M; Kirby C; Johnson M; Cox LW
    Clin Reprod Fertil; 1983 Jun; 2(2):129-42. PubMed ID: 6671191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.